These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 9285495)

  • 1. Growth factor alterations in advanced diabetic retinopathy: a possible role of blood retina barrier breakdown.
    Pfeiffer A; Spranger J; Meyer-Schwickerath R; Schatz H
    Diabetes; 1997 Sep; 46 Suppl 2():S26-30. PubMed ID: 9285495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitreous levels of the insulin-like growth factors I and II, and the insulin-like growth factor binding proteins 2 and 3, increase in neovascular eye disease. Studies in nondiabetic and diabetic subjects.
    Meyer-Schwickerath R; Pfeiffer A; Blum WF; Freyberger H; Klein M; Lösche C; Röllmann R; Schatz H
    J Clin Invest; 1993 Dec; 92(6):2620-5. PubMed ID: 7504689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retinal photocoagulation does not influence intraocular levels of IGF-I, IGF-II and IGF-BP3 in proliferative diabetic retinopathy-evidence for combined treatment of PDR with somatostatin analogues and retinal photocoagulation?
    Spranger J; Möhlig M; Osterhoff M; Bühnen J; Blum WF; Pfeiffer AF
    Horm Metab Res; 2001 May; 33(5):312-6. PubMed ID: 11440279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deficient activation and different expression of transforming growth factor-beta isoforms in active proliferative diabetic retinopathy and neovascular eye disease.
    Spranger J; Meyer-Schwickerath R; Klein M; Schatz H; Pfeiffer A
    Exp Clin Endocrinol Diabetes; 1999; 107(1):21-8. PubMed ID: 10077351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic levels contribute significantly to increased intraocular IGF-I, IGF-II and IGF-BP3 [correction of IFG-BP3] in proliferative diabetic retinopathy.
    Spranger J; Bühnen J; Jansen V; Krieg M; Meyer-Schwickerath R; Blum WF; Schatz H; Pfeiffer AF
    Horm Metab Res; 2000 May; 32(5):196-200. PubMed ID: 10871161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Free insulin growth factor-I and vascular endothelial growth factor in the vitreous fluid of patients with proliferative diabetic retinopathy.
    Simó R; Lecube A; Segura RM; García Arumí J; Hernández C
    Am J Ophthalmol; 2002 Sep; 134(3):376-82. PubMed ID: 12208249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitreous levels of IGF-I, IGF binding protein 1, and IGF binding protein 3 in proliferative diabetic retinopathy: a case-control study.
    Burgos R; Mateo C; Cantón A; Hernández C; Mesa J; Simó R
    Diabetes Care; 2000 Jan; 23(1):80-3. PubMed ID: 10857973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravitreal growth factors in proliferative diabetic retinopathy: correlation with neovascular activity and glycaemic management.
    Boulton M; Gregor Z; McLeod D; Charteris D; Jarvis-Evans J; Moriarty P; Khaliq A; Foreman D; Allamby D; Bardsley B
    Br J Ophthalmol; 1997 Mar; 81(3):228-33. PubMed ID: 9135388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transforming growth factor beta2 in the vitreous in proliferative diabetic retinopathy.
    Hirase K; Ikeda T; Sotozono C; Nishida K; Sawa H; Kinoshita S
    Arch Ophthalmol; 1998 Jun; 116(6):738-41. PubMed ID: 9639441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Free insulin-like growth factor 1 in the vitreous fluid of diabetic patients with proliferative diabetic retinopathy: a case-control study.
    Simó R; Hernández C; Segura RM; García-Arumí J; Sararols L; Burgos R; Cantón A; Mesa J
    Clin Sci (Lond); 2003 Mar; 104(3):223-30. PubMed ID: 12605576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in vitreous concentrations of human hepatocyte growth factor (hHGF) in proliferative diabetic retinopathy: implications for intraocular hHGF production.
    Nishimura M; Ikeda T; Ushiyama M; Kinoshita S; Yoshimura M
    Clin Sci (Lond); 2000 Jan; 98(1):9-14. PubMed ID: 10600653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship between the circulating IGF system and the presence of retinopathy in Type 1 diabetic patients.
    Frystyk J; Bek T; Flyvbjerg A; Skjaerbaek C; Ørskov H
    Diabet Med; 2003 Apr; 20(4):269-76. PubMed ID: 12675639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravitreous vascular endothelial growth factor and hypoxia-inducible factor 1a in patients with proliferative diabetic retinopathy.
    Wang X; Wang G; Wang Y
    Am J Ophthalmol; 2009 Dec; 148(6):883-9. PubMed ID: 19837381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistent secretion of vascular endothelial growth factor into the vitreous cavity in proliferative diabetic retinopathy after vitrectomy.
    Itakura H; Kishi S; Kotajima N; Murakami M
    Ophthalmology; 2004 Oct; 111(10):1880-4. PubMed ID: 15465550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin-like growth factors in vitreous. Studies in control and diabetic subjects with neovascularization.
    Grant M; Russell B; Fitzgerald C; Merimee TJ
    Diabetes; 1986 Apr; 35(4):416-20. PubMed ID: 2420665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitreal insulin-like growth factor binding proteins (IGFBPs) are increased in human and animal diabetics.
    Waldbillig RJ; Jones BE; Schoen TJ; Moshayedi P; Heidersbach S; Bitar MS; van Kuijk FJ; de Juan E; Kador P; Chader GJ
    Curr Eye Res; 1994 Jul; 13(7):539-46. PubMed ID: 7523030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution of IGF-I and -II, IGF binding proteins (IGFBPs) and IGFBP mRNA in ocular fluids and tissues: potential sites of synthesis of IGFBPs in aqueous and vitreous.
    Arnold DR; Moshayedi P; Schoen TJ; Jones BE; Chader GJ; Waldbillig RJ
    Exp Eye Res; 1993 May; 56(5):555-65. PubMed ID: 7684697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the vitreous proteome in diabetes without diabetic retinopathy and diabetes with proliferative diabetic retinopathy.
    Gao BB; Chen X; Timothy N; Aiello LP; Feener EP
    J Proteome Res; 2008 Jun; 7(6):2516-25. PubMed ID: 18433156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracellular matrix proteins in epiretinal membranes and in diabetic retinopathy.
    George B; Chen S; Chaudhary V; Gonder J; Chakrabarti S
    Curr Eye Res; 2009 Feb; 34(2):134-44. PubMed ID: 19219685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiogenic and antiangiogenic factors in proliferative diabetic retinopathy.
    Simó R; Carrasco E; García-Ramírez M; Hernández C
    Curr Diabetes Rev; 2006 Feb; 2(1):71-98. PubMed ID: 18220619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.